Multicenter Clinical Trial with a health product associated with a drug in therapeutic use authorized for the treatment of CVNMI, evaluating the efficacy and tolerability of adjuvant treatment with EMDA-MMC versus standard BCG and the efficacy of the biomarker
INV. CLINICA PRODUCT SANITARIO COM.
Clinical trial information
- Promoter: PRESURGY, SL
- Execution start: 01/07/2021
- End of execution: 30/12/2026
- IP: MIGUEL ARRABAL MARTIN